bismuth subcitrate + metronidazole + tetracycline Capsules 140 mg + 125 mg + 125 mg
Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Comments
Ref. product: Pylera® Axcan Pharma
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years.
Main therapeutic areas include diabetes, CNL, dermatology, and oncology.
Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments.
The company possesses 10+ manufacturing facilities that are cGMP-compliant.
Manufacturer usually replies in 16 days